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Animal prostaglandins and plant jasmonates are well-known 
enzymatically formed cyclopentanoic lipids that have regulatory 
functions and serve as inducible mediators of host defense 
reactions. A novel group of prostaglandin-like compounds, the 
isoprostanes, generated in animals and plants by a 
nonenzymatic, free radical-catalyzed process, are now 
suspected to be mediators of oxidant injury in viva. 
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Introduction 
Animals and plants, for hundreds of million years, have 
evolved defensive strategies to protect themselves against 
pathogens, parasites and oxidant injury. Although the 
mammalian immune system and the plant chemical 
defense system have a completely different design, some 
of the early intracellular signal events triggering specific 
cell responses and gene activation are strikingly similar. 
Among them, cyclopentanoic fatty acid derivatives such as 
prostaglandins and jasmonates are well-known signals that 
are generated within minutes by oxygenation and cycliza- 
tion of polyunsaturated fatty acids that are released from 
membrane lipids after receptor-mediated cell activation. 
Biosynthesis of prostaglandins (PCs) and jasmonates is 
catalyzed by enzymes that are constitutively expressed in 
most animal and plant tissues, respectively. In addition, a 
novel group of cyclopentanoids, the isoprostane (iP) 
family, which presumably can be synthesized by all 
aerobic organisms and cells utilizing polyunsaturated fatty 
acids as structural lipids in their membranes, has been dis- 
covered recently (Figure 1). 
Enzymatically formed cyclopentanoic signals 
in host defense: animal prostaglandins and 
plant jasmonates 
PGs, which are found in animals, are involved in a variety 
of physiological regulatory processes in kidney, bone, 
reproductive tissues, gut and blood vessels. But PG syn- 
thesis can also be triggered by inflammatory peptides, 
growth factors, cytokines, tumor promoters, microbial cell- 
wall fragments, cell injury and other stimuli; in these cir- 
cumstances, PGs contribute to inflammatory responses 
(such as redness, edema, pain and heat sensations) [l]. 
PGs also modulate fever [Z] and pain [3] in the nervous 
system. It is for this reason that anti-prostaglandin drugs 
such as aspirin, indomethacin and ibuprofen are used as 
standard anti-inflammatory therapeutics. 
The term prostaglandins refers strictly to eicosanoids that 
are generated from C20 fatty acids (predominantly arachi- 
donic acid) by the action of prostaglandin H synthase 
(PGHS) and have a characteristic cyclopentane ring 
system (Figure 2). As polyunsaturated C20 fatty acids and 
PGHS are generally lacking in bacteria, yeasts and higher 
plants (the former can be found in algae, mosses, ferns and 
filamentous fungi, PGs are presumably restricted to the 
animal kingdom [4-61. But plants do synthesize a group of 
structurally closely related cyclopentanoic acids such as 
12-oxo-phytodienoic acid, jasmonic acid and their two 
methylene groups shorter dinor congeners (commonly 
referred to as jasmonates) [7]. Jasmonates are derived from 
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Biosynthesis of prostaglandin-like compounds in animals and plants. of the membrane. In animals, arachidonate (AA) is the most common 
Animals and plants utilize their structural fatty acids in the membrane to precursor that is utilized for biosynthesis of prostaglandins (PGs) and 
form cyclopentanoic signal compounds. Prostaglandin H synthase (in isoprostanes (iPs). Higher plants utilize a-linolenate (Ln) for the 
animals only) and allene oxide synthase (in plants only) are the crucial synthesis of 1 P-oxo-phytodienoic acid (12-OPDA) and jasmonic acid or 
enzymes involved in the formation of animal-specific prostaglandin and dinor isoprostanes (dn-iPH). Prostaglandin H, (PGH,), isoprostane H, 
plant-specific jasmonate signals after liberation of the fatty acid from the (IPH,) and dinor isoprostane H, (dn-iPH,) are highly unstable, common 
membrane. Both animals and plants form isoprostanes via a intermediates not only for the formation of the E-ring structures shown, 
nonenzymatic, free-radical-catalyzed pathway from esterified fatty acids but for a variety of other ring types (see Figure 2) as well. 
the main polyunsaturated plant fatty acids a-linolenic [8] 
and hexadecatrienoic acid [9] by the action of lipoxyge- 
nase and allene oxide synthase. a-Linolenic acid is only a 
minor fatty acid in mammals and allene oxide synthase 
does not occur in animals. Jasmonates are therefore char- 
acteristic plant mediators. Like prostaglandins in animals, 
jasmonates function as physiological regulators, although 
the processes are rather different, including flowering, 
tendril coiling, tuberisation, fruit ripening and storage [7]. 
One of the most striking similarities of prostaglandins 
and jasmonates uncovered recently is their essential 
function in the reproductive system. Prostaglandins F, 
and E, are essential for normal parturition and perinatal 
survival of mice pups [lO,ll], whereas mutant plants 
unable to synthesize jasmonates have sterile anthers and 
produce no seed [l&13]. Another exciting similarity 
recently became apparent when it was shown that jas- 
monates effectively function as mediators in host defense 
reactions in response to wounding, pathogen attack and 
UV radiation injury [7]. PGs have a similar function that 
has long been recognized. Jasmonates are potent tran- 
scriptional activators that induce de ~OZIO synthesis of a 
variety of defensive proteins [14] and accumulation of 
defensive low molecular weight compounds [15]. Mutant 
plants deficient in jasmonate biosynthesis are therefore 
sensitive to a number of pathogens and administering 
exogenous jasmonate can be protective [16-181. Unfortu- 
nately, jasmonic acid has too many other effects to be 
used in agriculture as an inducer of endogenous plant 
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defense mechanisms. As structurally related jasmonate 
analogues display drastically different profiles of biologi- 
cal effects [19], thus, it might be possible to design ana- 
logues with more desirable biological characteristics. 
The isoprostanes: occurrence and mechanism 
of formation 
Animal isoprostanes 
Until recently, PGHS was regarded as obligatory for 
prostanoid synthesis, but, in 1990, a series of prosta- 
glandin-like compounds was reported to be produced in 
mammals by the free radical-catalyzed peroxidation of 
arachidonic acid independent of PGHS [ZO]. Isoprostanes 
have the same cyclopentane ring system and oxygen 
functionalities as PGs but differ from them by the cis- 
stereochemistry at the five-membered ring junction as 
compared with the trans-ring junction in all PGs. As for- 
mation of isoprostanes is nonenzymatic, the stereochem- 
istry at each of the chiral centers of the molecules can be 
either R or S. In addition, the isoprostane carbon skeleton 
can be identical (iP regioisomer III) to that of the PGs or 
differ in the lengths of the sidechains (regioisomers 
IV-VI), see Figure 1. Thus, up to 64 isomers of, for 
instance, prostaglandin-G-like compounds may poten- 
tially be produced. Isoprostane formation in vitro was first 
observed over three decades ago [Zl-231 but was not 
thought to be relevant in viuo. We now know that iso- 
prostanes occur ubiquitously in all mammalian tissues 
and extracellular fluids at concentrations that exceed 
those of PGs by more than an order of magnitude [24]. 
F2-ring isoprostanes (iPF,s), for instance, have been 
detected esterified in rat liver phospholipids (6 rig/g liver) 
and unesterified in fresh human plasma (35 pg/ml) and 
human urine (1.6 ng/mg creatinine) [ZS]. In viva, these 
compounds increase dramatically during enhanced free 
radical formation, exert potent receptor-mediated biologi- 
cal activity and represent extremely sensitive and accu- 
rate markers of oxidative stress [26]. 
Interestingly, the production of isoprostanes from the pre- 
cursor fatty acids (which are found almost completely 
esterified in the phospholipids and-in the case of 
plants - also in the glycolipids of membranes) appears to 
be by nonenzymatically oxygenation in situ [27]. Under 
physiological conditions, the level of free fatty acids in 
mammalian [‘28] and plant cells [29] is typically main- 
tained below 0.25-l% of the total amount of fatty acids by 
an efficient esterification mechanism. Free fatty acids are 
therefore only a minor source for cellular isoprostane for- 
mation [25]. Unesterified isoprostanes, representing less 
than 2% of the cellular isoprostanes, are thought to be 
derived predominately from preformed isoprostanes that 
were released by phospholipases [2.5]. In contrast, in the 
enzymatic pathways of both mammals and plants, the fatty 
acid must first be liberated by (phospho-)lipases to 
become available to biosynthetic enzymes (Figure 1). 
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Enzymatic and nonenzymatic metabolism of G-ring prostaglandins/ 
isoprostanes. A- to J-ring prostaglandinlisoprostane as well as A- and 
B-ring isothromboxane/ thromboxane (iTX/TX) structures are derived 
from G-ring precursors. The primary enzymatic G-ring metabolites are 
shown in the box. All these products may also be formed 
nonenzymatically, however. In plain buffer, H-ring structures isomerize 
rapidly to E- and D-ring prostanoids and may be subject to 
dehydrationlisomerization via an enol-enolate intermediate leading to 
A-, B- and J-ring compounds, respectively. In addition, J-ring 
structures are prone to undergo further isomerization and dehydration 
reactions [87]. In the physiological pH range, dehydration/ 
isomerization is a slow process, however [WI. The relatively stable 
F-ring can be formed in vitro and in viva in the presence of natural 
reductants [201. Thromboxane-A-like compounds are formed in vitro 
and in viva presumably by a heavy-metal-catalyzed mechanism and 
are rapidly hydrolyzed by water to iTXB/TXB [38]. 
Unesterified (iso-)prostanoids and jasmonates, however, 
cannot be esterified into membrane lipids. 
The first isoprostane formed by autoxidation, iPG, is an 
extremely reactive and versatile molecule that can readily 
be transformed to almost all known prostaglandin ring 
systems in o&o (Figure Z), many of which have already 
been shown to be biosynthesized nonenzymatically in viva. 
Plant isoprostanes 
Analysis of the mechanism of isoprostane formation (see 
below) and experimental evidence suggest that formation 
of isoprostane-like compounds will occur when a fatty acid 
containing at least one triene unit meets molecular oxygen 
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lsoprostane formation: the endoperoxide 
mechanism. Hydrogen abstraction from the 
bisallylic methylene group at carbon 6’ yields 
a pentadienyl radical that may be oxygenated 
at carbon 4’. The corresponding racemic 
peroxy radical may attack carbon 2’ yielding a 
racemic endoperoxy radical conformer which 
is stabilized in the geometry shown by 
delocalization into the radicaloid A orbital both 
from a P-peroxy oxygen lone pair and from the 
diene unit. Cyclization will involve rotation of 
syn rr: orbital lobes toward one another 
(disrotatory motion) and, as a consequence, 
the resulting bicycle endoperoxide will 
possess almost exclusively &-oriented 
appendages (either exe, exe or endo, endo) 
[341. Attack of the sidechain radical by oxygen 
and reduction of the sidechain peroxy radical 
yields a PGG-like structure. 
in the absence of an effective antioxidant. As mentioned 
previously, eicosanoids cannot be formed in higher plants. 
Instead, we have speculated that a-linolenic acid and 
hexadecatrienoic acid, which typically represent more 
than 40% and 10% of the total fatty acids in plant leaves 
[29], respectively, could substitute for arachidonate not 
only in the jasmonate but also in the isoprostane pathway. 
Isoprostanes derived from cl-linolenate would differ from 
mammalian isoprostanes in that they are two methylene 
groups shorter and retain only one double bond from the 
precursor. Recently, we have shown that the postulated 
El-dinor isoprostanes (see [30] for a discussion of the 
nomenclature) can indeed be detected in cell cultures of 
four taxonomically different plant species in a concentra- 
tion range of 5-60 rig/g of dry weight, which is more than 
one order of magnitude higher than normal jasmonate 
levels [31]. In addition, E,- and Fr-dinor isoprostanes have 
also been detected in whole plants of several species, sug- 
gesting that dinor isoprostanes represent common plant 
analogues of the animal isoprostanes (S. Parchmann and 
M. J.M., unpublished observations). 
The endoperoxide radical mechanism: nonenzymatic 
generation of iPG 
Reactive oxygen species are crucial in isoprostane forma- 
tion. They can readily abstract a hydrogen atom from 
bisallylic methylene groups of polyunsaturated fatty 
acids, starting a radical reaction that leads to the forma- 
tion of isoprostanes under aerobic conditions not only in 
vitro but also in animals and plants (Figure 3). As radical 
generation is nonenzymatic, all methylenes flanked by 
two cis double bonds can be involved in this reaction, 
although not necessarily to an equal extent [32]. After 
hydrogen abstraction, the pentadienyl radical can 
combine with 0, to generate a racemic peroxyl radical 
that is prone to rearrange to a bicycle endoperoxy radical, 
yielding equivalent amounts of ol,a- and P,P-endoperoxy 
radicals. Analysis of bicycle endoperoxides derived from 
Figure 4 
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Architecture and nomenclature of isoprostane regioisomers. A triene 
unit is the principal building block for all isoprostane ring systems 
(PGH ring system in this example). The substitutes at the triene unit 
represent the methyl (blue) and the carboxyl (yellow) terminus of the 
fatty acid. The methyl terminal chain at each distinct triene unit can 
occupy the position R, or R, of the isoprostane, and, thus, two types 
of regioisomers can be produced per triene unit. As shown, trienoic, 
tetraenoic and pentaenoic fatty acids will form 2, 4 and 6 different 
regioisomers, respectively. lsoprostane regioisomers can be best 
classified according to the recently proposed nomenclature by 
Rokach et a/. [30] (used throughout this article), which overcomes 
some important limitations of the previous nomenclature [891. 
Representative examples are (a) a-linolenate (n = 6), (b) y-linolenate 
(n = 3), (c) arachidonate (n = 2) and (d) eicosapentaenate (n = 2). 
y- and a-linolenate, and arachidonate revealed that the 
two sidechains are configured almost exclusively cis with 
respect to the cyclopentane ring [23,33,34]. Next, the 
bicycle endoperoxy radical can trap an oxygen on either 
face of the sidechain, yielding racemic hydroperoxy 
bicycle endoperoxy radicals. At this stage, termination of 
the radical chain reaction by hydrogen abstraction from a 
suitable donor molecule such as a polyunsaturated fatty 
acid or glutathione will yield iPG (Figure 3). 
The mechanism outlined above is principally applicable 
to polyunsaturated fatty acids that contain one or more 
triene units. Each triene unit has two mechanistically 
lsoprostane formation: the dioxetane mechanism. Cyclization of the 
8’-hydroperoxy radical via the dioxetane mechanism will yield two 
regioisomers (R and R’ are interchangeable) each of which is 
comprised of only two isomers if an enantiomerically pure hydroperoxy 
radical is the starting material. For instance, Corey and Wang 1361 
observed cyclization of the 15(S)-hydroperoxy radical of arachidonate 
to yield PGG, (natural chirality) and the 12-iso-PGG, epimer in a ratio 
of 1 :3 in 43% yield. 
equivalent but distinct substituents and will therefore 
form two different regioisomers (Figure 4), each of which 
is theoretically composed of eight racemic diastereomers 
(including the minor sidechain trans-substituted isomers, 
not shown in Figure 3). For example, linolenate can form 
32 stereoisomers and arachidonate will yield 64 stereoiso- 
mers. Although synthesis of bicycle endoperoxides from 
dienoic fatty acids appears theoretically feasible, as yet no 
indication of the formation of such compounds from, for 
example, linoleic acid has been obtained [35]. 
The dioxetane mechanism: an alternative pathway for 
isoprostane formation 
Recently, Corey and Wang [36] have shown that iso- 
prostanes can not only be formed via the endoperoxide 
mechanism described above, but also by an alternative 
free-radical-catalyzed pathway in vitro. The alternative 
dioxetane mechanism starts from the l’- and 8’-hydro- 
peroxy radicals (Figure 5) rather than from the 4’- and 
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5’-hydroperoxy radicals (Figure 3) that are required for 
the endoperoxide mechanism. This route will also lead 
to the same two regioisomers per triene subunit as the 
endoperoxide mechanism and, presumably, also operates 
in animals and plants. Interestingly, this pathway is 
much more stereoselective than the endoperoxide mech- 
anism and yields two regioisomers, each of which is com- 
prised of two racemic diastereomers, one of which has 
the sidechain cis substitution at the cyclopentane ring, 
whereas the other one has the tram configuration. This 
finding casts doubt upon the commonly held belief that 
autoxidation of polyunsaturated fatty acids yields almost 
exclusively cis substituted prostaglandin-like com- 
pounds. Earlier studies have dealt predominately with 
13(S)-hydroperoxy a-linolenic acid, 9(S)-hydroperoxy 
y-linolenic acid or chemical model compounds as starting 
material that cannot undergo the dioxetane mechanism 
and thus forms predominately cis substituted prosta- 
glandin-like compounds [23,33,34]. The relative contribu- 
tion of these two pathways in isoprostane formation in 
vitro and in viva remains to be evaluated, however. 
The highly unstable isoprostane iPG can be converted 
nonenzymatically to D-, E- and F-ring isoprostanes 
and isothromboxane B in viva 
In mammalian cells, the PGHS products PGG and PGH 
are the common precursors for PGD, PGE, PGF, PGI and 
thromboxane A, reactions catalyzed by prostaglandin D, E, 
F, I and thromboxane A synthases, respectively. The spec- 
trum of products formed (Figure 2, boxed structures) in a 
specific cell type will critically depend on the presence of 
one or more of these enzymes. All of these prostaglandin 
ring systems, except for PGI, have been shown, however, 
to be produced by nonenzymatic reactions from the 
common PGG- or PGH-ring system (Figure 2). As the G- 
and H-ring endoperoxide structures are extremely labile 
compounds with a half-life of -5 min in aqueous medium 
[37], they can isomerize rapidly to PGE- and PGD-like 
compounds, both in vitro and in vjvo [38,39]. 
Only small quantities of iPFs are formed from iPGs in 
plain buffer in vitro, but iPFs are found in similar concen- 
trations to iPDs and iPEs in vjvo [38]. A mechanism has 
been proposed that involves the reduction of either iPG or 
iPH to iPFs by naturally occurring reductants such as 
glutathione, hematin, lipoic acid, polyunsaturated fatty 
acids or glutathione peroxidase [ZO]. Isothromboxane 
(iTX)-like compounds are not formed from iPG or iPH 
unless iron is present in a complex such as hemin in vitro 
[40]. iTXs occur in mammals, however, in similar concen- 
trations to the isoprostanes described above, but the exact 
mechanism of formation in viva has not yet been clarified 
[38]. As the biosynthesis of isoprostanes proceeds predom- 
inately within the membrane it is assumed that the contri- 
bution of enzymes to the formation of iPG or iPH 
metabolites in a&o is negligible. 
Endoperoxide radical mechanism (almost perfectly) under 
steric control: the prostaglandin H synthases 
The enzymatic biosynthesis of prostaglandins in animals 
also proceeds via a radical mechanism that is under the tight 
control of PGHS, and thus yields, predominately, a single 
stereoisomer (Figure 6). Two PGHS isozymes, PGHS-1 
and PGHS-2, have been purified as homodimers with a 
subunit molecular mass of about 72 kDa. The enzyme con- 
tains heme (one per subunit) that is required for its two cat- 
alytic activities - as a cyclooxygenase and a peroxidase [6]. 
Despite the complex chemistry involved, the steps in the 
cyclooxygenase reaction and those in nonenzymatic fatty 
acid auto-oxidation show considerable similarities. Appar- 
ently, the function of the enzyme appears to be rather 
simple - fixation of the conformation of the substrate and 
stereospecific hydrogen removal. Additionally, the enzyme 
favours the correct radical rearrangements and shields the 
intermediate radicals to prevent side reactions. 
Neither PGHS-1 nor PGHS-2 acts in a strictly stereospe- 
cific manner, however. Both isozymes form small amounts 
of the isoprostane 8iso-PGF,, (but no other F2-iso- 
prostanes). The amounts of 8-iso-PGF,, formed by acti- 
vated human platelets (containing PGHS-1) and monocytes 
(containing PGHS-2) are only -0.05-O. 1% and -050.8% of 
the amount of thromboxane formed, respectively [41,42]. 
Enzymatic formation of 8-iso-PGF2, is commonly believed 
to contribute only insignificant amounts to overall 8-iso- 
PGF,, biosynthesis in vjvo, however. So 8-iso-PGF,, can 
still be used as an index of oxidant stress (see below). 
Significance and putative function of 
isoprostanes 
Isoprostanes have stimulated great interest, as potential 
mediators of oxidant injury, as agents that might disturb 
the physical properties and normal function of cell mem- 
branes, and as markers of oxidative stress. So far, studies 
in these areas have been limited exclusively to C20 iso- 
prostanes in mammals and nothing is yet known about the 
biological significance of the recently discovered dinor iso- 
prostanes in plants. 
lsoprostanes have potent, receptor-mediated biological 
activities in mammals 
Only a few isoprostanes are now available as pure isomers 
obtained by total synthesis, including 8-iso-PGF,, and 
8-iso-PGE,, which are two of the most abundant iso- 
prostanes of arachidonate autoxidation. 
The availability of these compounds has allowed exten- 
sive testing of their biological activities. Many studies 
have shown that isoprostanes are potent vasoconstrictors 
in a variety of tissues. For instance, 8-iso-PGF,, [43,44] 
and 8-iso-PGE, [45] are extremely potent constrictors of 
the afferent renal arteriole, leading to a drop in glomerular 
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Figure 6 
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Prostaglandin synthesis: proposed reaction mechanism of PGH radical chain reaction within the substrate is terminated by its reduction 
synthases. The reaction starts with a two-electron reduction of a to PGG, and regeneration of the tyrosyl radical of the enzyme. The 
hydroperoxide, which is necessary to activate the enzyme by oxidation of tyrosyl radical must be reduced by natural reductants such as uric acid 
the protoporphyrin IX (PPIX) with iron in the ferric form (hematin). Upon or glutathione before the peroxidase can act. The cyclooxygenase and 
reaction with the hydroperoxide, hematin is oxidized and a tyrosyl radical peroxidase activities of PGHS appear to be associated with spatially 
is formed that can stereospecifically abstract the 13 pro-(S) hydrogen distinct yet interactive sites on the enzyme. The hydroperoxy group of 
from arachidonic acid. This, in turn, leads to the formation of a carbon PGG, can be reduced to the corresponding hydroxy group by oxidation 
radical that undergoes a similar reaction sequence as in autoxidation. of hematin to an oxo-ferry1 intermediate, which is thought to abstract an 
Because of the spatial orientation of arachidonate in the active site, the electron from Tyr385, thereby preparing the enzyme for a new cycle of 
oxygenation and cyclization steps occur in a stereo-specific fashion. The arachidonate turnover [6,90]. 
capillary pressure and filtration rate in the low nanomolar 
range. S-iso-PGF,, is also a potent vasoconstrictor in liver 
[46], heart [47,48], lung [49] and the eye retina [SO]. The 
potency of 8-iso-prostaglandin E, in the guinea pig heart 
[48] is almost identical to 8-iso-PGF,,. These findings 
were surprising, because the prostaglandins PGE and 
PGF, the cognate ligands of PGE and PGF receptors, 
generally have opposite effects on smooth muscle cells of 
the vasculature - PGE, is a vasodilator and PGF,, is a 
vasoconstrictor. 
Interestingly, all the effects of 8-iso-PGF,, and 8-iso-PGE, 
in the aforementioned studies were almost completely abro- 
gated by thromboxane A, receptor antagonists, suggesting 
that these isoprostanes might act via a common thromb- 
oxane receptor. Although 8-iso-PGF,, does functionally 
interact with the thromboxane A, receptor [Sl], binding 
characteristics and functional studies suggest that its physio- 
logical plasma concentrations are far below the micromolar 
concentrations required to affect platelet responses medi- 
ated by the thromboxane A, receptor in n& [%?I. 
In contrast, 8-iso-PGF,, and 8-iso-PGE, are much more 
potent than thromboxane A, receptor agonists in inducing a 
functional response on vascular smooth muscle cells [45,53], 
suggesting that other mechanisms mediate these effects in 
aivo. Low (Kd = 0.94 FM) and high (Kd = 32 nM) affinity 
binding sites were found for 8-iso-PGF,, that have been 
attributed to binding of 8-iso-PGF,, to the thromboxane A, 
receptor and to a hypothetical high-affinity isoprostane 
receptor that is also sensitive to thromboxane A, receptor 
antagonists, respectively [54,55]. In addition, a novel mech- 
anism for the vasoconstrictor action of 8-iso-PGF,, on 
retinal blood vessels was reported recently. In the eye, 8-iso- 
PGF,, may contract retinal vessels with an EC,, of about 
6 nM via stimulation of endothelin release and PGHS-gen- 
erated thromboxane formation [50]. 8-ko-PGF2, also has a 
pronounced effect on smooth muscles other than those of 
the vasculature and might cause bronchoconstriction 
[56-581, as well as contraction of peripheral lymphatics [59]. 
Much less information is available on the biological activi- 
ties of other isoprostanes. For instance, 12-iso-PGF,, was 
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shown to functionally activate the ocular PGF,, receptor, 
albeit less potently (EC,, = 5 FM) than PGF,, (EC,, = 
10 nM) [60], whereas several other Fz-isoprostanes, includ- 
ing 8-i.r+PGF,,, caused little or no activation. Other estab- 
lished biological activities of 12-iso-PGF,, include 
stimulation of mitogenesis in NIH 3T3 cells [60] and 
hypertrophy of cardiomyocytes [61]. Interestingly, 12-iso- 
PGF,, was a weak agonist of the heart myocyte PGF,, 
receptor but a potent inducer of myocyte hypertrophy 
(IC,, -150-200 nM) via a different signaling pathway to 
that activated by PGF,, 
Apparently, there are several mechanisms by which multi- 
ple species of isoprostanes induce vasoconstriction, bron- 
choconstriction and mitogenesis. Some isoprostanes 
appear to react incidentally with prostaglandin receptors 
(often in the micromolar range) but there is evidence that 
some of the isoprostanes might interact at low concentra- 
tions (nanomolar range) with specific isoprostane recep- 
tor(s). None of these putative isoprostane receptors has 
been cloned, however. 
lsoprostanes might cause physical damage and 
dysfunction of membranes 
Free radicals cause lipid peroxidation that might result in 
the alteration of the physical and functional properties of 
cellular membranes, such as plasma leakage and modilica- 
tion of transport properties. Under physiological conditions, 
the respiratory chain, the photosynthetic apparatus of plants 
and cytochrome P450 enzymes are thought to generate the 
vast majority of reactive oxygen species. It might therefore 
be expected that isoprostanes would be found in the corre- 
sponding membranes of mitochondria, chloroplasts, endo- 
plasmic reticulum and nuclei. In addition, autoxidation 
processes, the oxidative burst of leukocytes and elicited 
plant cells, and chemical oxidants presumably lead to an 
accumulation of isoprostanes in the cell membrane. The 
subcellular distribution of isoprostanes and their effect on 
specialized membranes is not known, however. 
As isoprostane-containing phospholipids are extremely 
kinked molecules, they are expected to have profound 
effects on the fluidity and integrity of membranes [ZS]. In 
vitro studies on artificial membranes suggested that struc- 
tural and functional membrane alterations occur when the 
oxidation of the membrane phospholipids exceeds 3-S% 
[62]. Such a degree of oxidation has been reported for 
mitochondrial membranes of rabbit reticulocytes that are 
degraded during the maturation of red blood cells [63]. In 
tissues with enhanced free radical production, such as in 
atheriosclerotic lesions, a hydroperoxylinoleate/linoleate 
ratio of 0.1-l% and an isoprostane/arachidonate ratio of 
about 15 ppm was found, suggesting that isoprostane-con- 
taining phospholipids are only minor components of a 
much larger pool of oxidized lipids [62]. The possible 
effect of elevated isoprostane-containing phospholipid 
levels on the physical properties of membranes remains 
to be demonstrated in vivo. 
lsoprostanes are accurate and sensitive markers of oxidant 
stress 
Although isoprostanes have been used as markers of 
oxidant injury for only a few years, an increasing number 
of studies has demonstrated that they represent extremely 
sensitive and reliable markers of oxidative stress [64], cor- 
relating well with other classical oxidative stress indices 
[65]. As common markers of oxidative stress such as lipid 
peroxides, malondialdehyde, alkanes and aldehydes are 
derived, at least in part, from enzymatic processes, are 
metabolically or chemically unstable and are, in some 
cases, volatile, they have often been unreliable as a 
measure of free radical injury in v&o [66]. F2-isoprostanes 
overcome most of these limitations because they are 
chemically stable end products generated by a free- 
radical-catalyzed process from specific fatty acids. As they 
are esterified in membranes, they represent a long-lasting 
marker of oxidant injury and enable the site of endoge- 
nous lipid peroxidation to be identified [26]. Furthermore, 
urinary isoprostanes and isoprostane metabolites represent 
an ideal noninvasive index of systemic oxidative stress. 
In most studies, the isoprostane 8-iso-PGF,, has served as a 
marker for isoprostane formation and oxidative stress in 
vitro and in vivo, but iPF,,-VI would be an attractive alter- 
native because it is more abundant in urine [67]. Fq-iso- 
prostanes generated from docosahexaenoic acid could be 
suitable markers in special tissues such as brain, which is 
particularly enriched with this fatty acid [68,69]. Iso- 
prostanes can be measured in plasma, in urine or after 
hydrolysis of tissue phospholipids by radio- and enzyme- 
immunoassay or - more specifically - using GC-MS [70]. 
Increased plasma and urinary isoprostanes have been mea- 
sured after intoxication and in several syndromes sus- 
pected to be associated with excessive generation of free 
radicals, including poisoning with paraquat [71] and Ccl, 
[72], halothan treatment [73], smoking [74], alcohol- 
induced liver disease [75], hepatic cirrhosis [76], coronary 
[77] and liver [78] reperfusion after ischemia, and athero- 
sclerosis (in atherosclerotic lesions) [62]. Elevated iso- 
prostane levels were also measured in patients with 
hepatorenal syndrome [79], scleroderma [80] and hyper- 
cholesterolemia [81]. In addition, isoprostane analysis 
greatly exceeds the value of other standard approaches to 
assess the effectiveness of antioxidants in vitro and in viva 
and might help to establish reliable dose-response rela- 
tionships of antioxidant treatments in clinical trials [82-861. 
As plants do not produce eicosanoids, dinor isoprostanes 
derived from a-linolenic acid could, potentially, be used 
as an index of oxidative stress status in plants or as a 
measure of oxidative degradation of plant products. 
lsoprostanes - a perspective for future research 
The discovery of isoprostanes as products of free-radical- 
induced lipid peroxidation has opened up new avenues 
of research regarding the role of oxidant injury in human 
and plant physiology. Not only has it been shown that 
isoprostanes increase during several human disorders 
associated with enhanced free-radical generation but also 
that several isoprostanes exert potent biological effects 
such as vasoconstriction, bronchoconstriction and mito- 
genesis. Detailed physiological investigations into how 
these events might be linked in z&o have only just 
begun, however. 
Reactive oxygen species have also been implicated in 
oxidative damage of plant organs and as mediators of plant 
systemic acquired resistance against pathogens. The prin- 
cipal inducible defenses against reactive oxygen species in 
plants include detoxifying enzymes (e.g. catalase and 
superoxide dismutase), low molecular weight secondary 
products with antioxidant activity and activation of patho- 
genesis related genes. Little is known about how reactive 
oxygen species trigger these responses. Plant dinor iso- 
prostanes might, by analogy to the mammalian pathway, 
play a functional role but this still remains to be eluci- 
dated. It will be exciting to see if isoprostanes have any 
general functions in response to oxidative stress in both 
plants and animals and to elucidate their full spectrum of 
biological activities. 
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